Sector
ChemicalsOpen
₹33.19Prev. Close
₹32.21Turnover(Lac.)
₹0.02Day's High
₹33.19Day's Low
₹31.552 Week's High
₹6452 Week's Low
₹27.25Book Value
₹15.42Face Value
₹10Mkt Cap (₹ Cr.)
15.85P/E
50.32EPS
0.63Divi. Yield
016 Apr 2025
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 5 | 5 | 5 | 5 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 2.41 | 1.67 | 1.17 | 0.7 |
Net Worth | 7.41 | 6.67 | 6.17 | 5.7 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 0.36 | 6.99 | 3.39 | 1.26 |
yoy growth (%) | -94.77 | 105.85 | 168.84 | -51.65 |
Raw materials | -0.12 | -3.53 | -1.54 | -0.62 |
As % of sales | 34.4 | 50.52 | 45.37 | 49.55 |
Employee costs | -0.77 | -0.63 | -0.57 | -0.4 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 0.93 | 2.25 | 1 | 0.79 |
Depreciation | -0.09 | -0.05 | -0.05 | -0.05 |
Tax paid | -0.45 | -0.8 | 0.01 | 0.11 |
Working capital | 0.52 | 1.83 | 1.28 | -0.03 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -94.77 | 105.85 | 168.84 | -51.65 |
Op profit growth | -205.7 | -308.67 | 0.71 | -275.86 |
EBIT growth | -58.68 | 125.09 | 25.84 | -33.27 |
Net profit growth | -67.21 | 92.35 | -17.48 | -23.14 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Pidilite Industries Ltd PIDILITIND | 3,065.35 | 74.64 | 1,55,918.64 | 445.76 | 0.65 | 2,850.86 | 190.23 |
SRF Ltd SRF | 3,254.8 | 76.15 | 96,480.35 | 513.16 | 0.22 | 3,402.88 | 389.29 |
Linde India Ltd LINDEINDIA | 6,763.1 | 128.8 | 57,675.72 | 117.9 | 0 | 591.88 | 443.12 |
Godrej Industries Ltd GODREJIND | 1,134.35 | 201.48 | 38,199.47 | -68.32 | 0 | 1,086.41 | 50.63 |
Gujarat Fluorochemicals Ltd FLUOROCHEM | 3,417.1 | 65.29 | 37,536.84 | 167 | 0.09 | 1,158 | 588.43 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
MSR Ayyangar
Non Executive Director
Anuradha Raghavan
Non Executive Director
Sarada Raghavan
Executive Director & CFO
Jayavel Balaiah Nadar
Company Sec. & Compli. Officer
Priyanka Omprakash Sharma
Independent Director
Milind S Desai
Independent Director
Dinesh Kumar Deora
Independent Director
V Ranganathan
Plot No T-3/2 MIDC Area,
P O Box No 39 Taloja,
Maharashtra - 410208
Tel: 91-022-20870587
Website: http://www.ebnl.org
Email: investors@ebnl.org
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: paytm.ipo@linkintime.co.in
Summary
Emmessar Biotech & Nutrition Limited, originally established on 17th March 1992 as Emmessar Chemical Industries Ltd (ECIL) started its operations in manufacturing Super Specialty Fine Chemicals. The C...
Read More
Reports by Emmessar Biotech & Nutrition Ltd
What is the Emmessar Biotech & Nutrition Ltd share price today?
What is the Market Cap of Emmessar Biotech & Nutrition Ltd?
What is the PE and PB ratio of Emmessar Biotech & Nutrition Ltd?
What is the 52 Week High and Low of Emmessar Biotech & Nutrition Ltd?
What is the CAGR of Emmessar Biotech & Nutrition Ltd?
What is the shareholding pattern of Emmessar Biotech & Nutrition Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.